Measles, Mumps, and Rubella - Centers for Disease Control and ...

More documents

Recommendations

Info

36 MMWR May 22, 1998preparation becomes necessary because of imminent exposure to disease, MMR or itscomponent vaccines can be administered simultaneously with the IG preparation,although vaccine-induced immunity may be compromised. Usually, vaccine virus replicationand stimulation of immunity will occur 1–2 weeks after vaccination. Thus, ifthe interval between administration of any of these vaccines and administration of anIG preparation is
Vol. 47 / No. RR-8 MMWR 37SteroidsSystemically absorbed corticosteroids can suppress the immune system of an otherwisehealthy person. However, neither the minimum dose nor the duration oftherapy sufficient to cause immune suppression are well defined. Most experts agreethat steroid therapy usually does not contraindicate administration of live virus vaccinessuch as MMR and its component vaccines when therapy is: a) short term (i.e.,
Page 1 and 2: May 22, 1998 / Vol. 47 / No. RR-8TM
Page 3 and 4: Vol. 47 / No. RR-8 MMWR iContentsIn
Page 5 and 6: Vol. 47 / No. RR-8 MMWR iiiAdvisory
Page 7 and 8: Vol. 47 / No. RR-8 MMWR vAdvisory C
Page 9 and 10: Vol. 47 / No. RR-8 MMWR 1Measles, M
Page 11 and 12: Vol. 47 / No. RR-8 MMWR 3greatest d
Page 13 and 14: Vol. 47 / No. RR-8 MMWR 5Rubella El
Page 15 and 16: Vol. 47 / No. RR-8 MMWR 7intermedia
Page 17 and 18: Vol. 47 / No. RR-8 MMWR 9Vaccine Sh
Page 19 and 20: TABLE 1. Acceptable presumptive evi
Page 21 and 22: Vol. 47 / No. RR-8 MMWR 13When meas
Page 23 and 24: Vol. 47 / No. RR-8 MMWR 15evidence
Page 25 and 26: Vol. 47 / No. RR-8 MMWR 17Women of
Page 27 and 28: Vol. 47 / No. RR-8 MMWR 194% among
Page 29 and 30: Vol. 47 / No. RR-8 MMWR 21SPECIAL C
Page 31 and 32: Vol. 47 / No. RR-8 MMWR 23protectio
Page 33 and 34: Vol. 47 / No. RR-8 MMWR 25Passively
Page 35 and 36: Vol. 47 / No. RR-8 MMWR 27are liste
Page 37 and 38: Vol. 47 / No. RR-8 MMWR 29In 1994,
Page 39 and 40: Vol. 47 / No. RR-8 MMWR 31women, th
Page 41 and 42: Vol. 47 / No. RR-8 MMWR 33observed
Page 43: Vol. 47 / No. RR-8 MMWR 35a contact
Page 47 and 48: Vol. 47 / No. RR-8 MMWR 39• is no
Page 49 and 50: Vol. 47 / No. RR-8 MMWR 41Measles O
Page 51 and 52: Vol. 47 / No. RR-8 MMWR 43Cases mee
Page 53 and 54: Vol. 47 / No. RR-8 MMWR 45rubella-s
Page 55 and 56: Vol. 47 / No. RR-8 MMWR 47Laborator
Page 57 and 58: Vol. 47 / No. RR-8 MMWR 4927. Lee S
Page 59 and 60: Vol. 47 / No. RR-8 MMWR 5181. Briss
Page 61 and 62: Vol. 47 / No. RR-8 MMWR 53130. CDC.
Page 63 and 64: Vol. 47 / No. RR-8 MMWR 55179. Amer
Page 65 and 66: Vol. 47 / No. RR-8 MMWR 57230. Amer
Page 67: MMWRThe Morbidity and Mortality Wee

Measles, Mumps, and Rubella - Centers for Disease Control and ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?